Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

FRANK B CORTAZAR

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1699060368
CMS profile
1037741
Location
ALBANY, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$92,409.71

93 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–93 of 93 matching records. This page contains 43 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

FRANK B CORTAZAR

NPI 1699060368 · CMS profile ID 1037741

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

ALBANY, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–93 of 93 matching records. This page contains 43 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1699060368?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
FRANK B CORTAZAR, NPI 1699060368, CMS profile ID 1037741. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–93 of 93 matching records. This page contains 43 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1699060368?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). FRANK B CORTAZAR, NPI 1699060368, CMS profile ID 1037741. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–93 of 93 matching records. This page contains 43 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1699060368?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
FRANK B CORTAZAR, NPI 1699060368, CMS profile ID 1037741, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–93 of 93 matching records. This page contains 43 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1699060368?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

93 matching records · $92,409.71 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 93 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–93 of 93.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $2,645.0006/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117532012 CMS
CALLIDITAS THERAPEUTICS US INC. $800.0006/05/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141516403 CMS
Amgen Inc. $24.8205/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111554577 CMS
Amgen Inc. $1,143.6505/15/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229368 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $33.7405/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118113577 CMS
Amgen Inc. $3,174.0005/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229358 CMS
Amgen Inc. $1,058.0005/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229362 CMS
Amgen Inc. $210.8105/10/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229370 CMS
Amgen Inc. $274.6305/10/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229378 CMS
Amgen Inc. $109.4005/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229372 CMS
Amgen Inc. $184.9205/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229376 CMS
Amgen Inc. $400.3105/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229380 CMS
CALLIDITAS THERAPEUTICS US INC. $800.0005/09/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141514803 CMS
Amgen Inc. $2,645.0004/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229354 CMS
Amgen Inc. $2,645.0004/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229348 CMS
Travere Therapeutics, Inc. $800.0004/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149878429 CMS
Travere Therapeutics, Inc. $1,200.0004/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149878433 CMS
Novartis Pharmaceuticals Corporation $33.9604/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086755951 CMS
Alnylam Pharmaceuticals Inc. $19.1104/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125833435 CMS
Amgen Inc. $2,645.0004/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229352 CMS
Amgen Inc. $2,645.0004/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117532010 CMS
Amgen Inc. $674.9404/10/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229366 CMS
Alexion Pharmaceuticals, Inc. $17.0604/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093940863 CMS
Amgen Inc. $2,645.0004/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229346 CMS
Amgen Inc. $2,645.0004/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229350 CMS
Amgen Inc. $11.8604/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229340 CMS
Amgen Inc. $11.8604/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229344 CMS
GlaxoSmithKline, LLC. $29.5703/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116688135 CMS
Amgen Inc. $124.7603/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111554579 CMS
CALLIDITAS THERAPEUTICS US INC. $1,600.0003/21/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141511787 CMS
CALLIDITAS THERAPEUTICS US INC. $24.9703/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141511671 CMS
Amgen Inc. $15.0903/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111554575 CMS
AstraZeneca Pharmaceuticals LP $115.2003/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105859208 CMS
CALLIDITAS THERAPEUTICS US INC. $1,600.0003/14/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141511361 CMS
Travere Therapeutics, Inc. $400.0003/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149878421 CMS
AstraZeneca Pharmaceuticals LP $13.4503/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105749531 CMS
AstraZeneca Pharmaceuticals LP $18.7003/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105420011 CMS
CALLIDITAS THERAPEUTICS US INC. $600.0002/28/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141510320 CMS
GlaxoSmithKline, LLC. $18.3102/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116285316 CMS
Amgen Inc. $2,645.0002/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117229342 CMS
CALLIDITAS THERAPEUTICS US INC. $23.1402/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141509405 CMS
Alnylam Pharmaceuticals Inc. $25.6702/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125833403 CMS
CALLIDITAS THERAPEUTICS US INC. $1,600.0001/17/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141508149 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $1,528.13 2
PY2021 $6,601.89 24
PY2022 $33,407.59 42
PY2023 $88,485.26 73
PY2024 $92,409.71 93
PY2025 $66,556.56 61

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $4,910.76 1
PY2025 Principal investigator $735,865.96 10
PY2024 Recipient $3,261.85 1
PY2024 Principal investigator $89,415.88 7
PY2023 Principal investigator $18,860.16 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $203,548.59 10/02/2025 Non-covered Recipient Entity
NEW YORK NEPHROLOGY
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function No dispute reported 06/30/2026 1190312541
Principal investigator 1 Amgen Inc. $169.00 09/30/2025 Non-covered Recipient Entity
NEW YORK NEPHROLOGY
A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis No dispute reported 06/30/2026 1246645153
Principal investigator 1 Travere Therapeutics, Inc. $4,500.00 07/11/2025 Non-covered Recipient Entity
NEW YORK NEPHROLOGY
Spartacus No dispute reported 06/30/2026 1244187174
Recipient Amgen Inc. $4,910.76 06/02/2025 Covered Recipient Physician Ph3 Avacopan in subjects with ANCA-associated vasculitis (pivotal study ADVOCATE) No dispute reported 06/30/2026 1246637132
Principal investigator 1 Amgen Inc. $286,339.32 02/25/2025 Non-covered Recipient Entity
NEW YORK NEPHROLOGY VASCULITIS AND GLOMERULAR CENTER
A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis No dispute reported 06/30/2026 1246645145
Principal investigator 1 Novartis Pharmaceuticals Corporation $2,278.17 02/25/2025 Non-covered Recipient Entity
NY NEPHROLOGY
A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy No dispute reported 06/30/2026 1190312545
Principal investigator 1 Novartis Pharmaceuticals Corporation $11,538.20 02/21/2025 Non-covered Recipient Entity
CAPITAL DISTRICT HEMATOLOGY ONCOLOGY ASSOCIATION
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of BION-1301 in Adults With IgA Nephropathy (The BEYOND Study) No dispute reported 06/30/2026 1190312969
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $56,979.29 01/29/2025 Non-covered Recipient Entity
NEW YORK NEPHROLOGY AND DIALYSIS ACCESS SURGERY
An Open-Label, Multiple-Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Different Dose Levels of Povetacicept in Subjects With Autoantibody-Associated Glomerular Diseases (RUBY-3) No dispute reported 06/30/2026 1214124268
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $134,230.41 01/24/2025 Non-covered Recipient Entity
NEW YORK NEPHROLOGY VASCULITIS AND GLOMERULAR CENTER
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER) No dispute reported 06/30/2026 1214124838
Principal investigator 1 Novartis Pharmaceuticals Corporation $2,594.03 01/22/2025 Non-covered Recipient Entity
NY NEPHROLOGY
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function No dispute reported 06/30/2026 1190312543
Principal investigator 1 Novartis Pharmaceuticals Corporation $33,688.95 01/09/2025 Non-covered Recipient Entity
NEW YORK NEPHROLOGY
A randomized, double-blind, parallel group, placebo-controlled, multicenter phase 3 trial to evaluate the efficacy, safety and tolerability of ianalumab on top of standard-of-care therapy in patients with active lupus No dispute reported 06/30/2026 1190308330